One expert explains how bispecific antibodies are a ‘targeted and effective’ option for patients with multiple myeloma. Bispecific antibodies offer a “targeted and effective alternative” for the ...

Monoclonal antibodies are widely used to treat diseases ranging from cancer to autoimmune disorders. The safety and efficacy of these biologic drugs depend on maintaining their correct ...

The race is on for new treatments that stand up to omicron's explosive spread. With omicron's explosive spread threatening to outpace current COVID-19 treatments, the race is on to find new options ...

Antibodies are immune proteins that our bodies produce to help fight off infection. Where they recognize and bind a pathogen — and how — can give important clues to the microbe’s vulnerabilities. Fred ...

Researchers at the University of Southampton have developed a promising new way to bolster the body's immune system response to cancer. Subscribe to our newsletter for the latest sci-tech news updates ...

Mode of action of the new microscopy method LLS-TDI-DNA-PAINT. On the top right, the RTX antibody was visualised on a Raij-B cell: it is easy to see how it links the CD20 molecules in the membrane.

When the body encounters an infectious agent like SARS-CoV-2, it produces antibodies that detect and neutralize it. The antibodies bind to distinct proteins on the virus’s surface called antigens. As ...

ST. LOUIS (KTVI) – Monoclonal antibody treatments received a thumbs up from a study by the Mayo Clinic released Monday. The study suggests the treatment can help those who are at high risk of serious ...

A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.

Monoclonal antibodies are a type of biologic medication that can treat moderate to severe inflammatory bowel disease (IBD) by targeting specific inflammatory processes in your body. Your doctor might ...

Dr. Amany Keruakous discussed how bispecific antibodies for multiple myeloma work by simultaneously targeting cancer cells and T cells. Dr. Amany Keruakous sat down for an interview with CURE, in ...